Lv1
18 积分 2022-04-10 加入
Sacituzumab Tirumotecan in EGFR-TKI–Resistant, EGFR-Mutated Advanced NSCLC
1个月前
已完结
Perivascular Niche–Resident Alveolar Macrophages Promote Interstitial Pneumonitis Related to Trastuzumab Deruxtecan Treatment
2个月前
已完结
Preclinical Development and a Case Report of a Nanobody-Based CLDN18.2 CAR-T IMC002 with Reduced On-Target Off-Tumor Toxicity
6个月前
已完结
Potentiating CAR-T cell function in the immunosuppressive tumor microenvironment by inverting the TGF-β signal
10个月前
已完结
Acquired resistance to immunotherapy by physical barriers with cancer cell-expressing collagens in non-small cell lung cancer
1年前
已完结
Epigenetic Therapies for Cancer
1年前
已完结
皖公网安备34019202002308
